Biotech stocks came under pressure in the week ended July 31 amid mixed earnings from the sector and some adverse clinical readouts.COVID-19 news flow continued to pour in, with big pharma tie-ups flaunting positive tidings. In the biggest ever coronavirus funding deal, the Sanofi SA (NASDAQ: SNY) GlaxoSmithKline plc (NYSE: GSK) won a joint $2.1 billion U.S. federal funding award.Here’re the key catalysts for the unfolding week:Conferences72nd National Hemophilia Foundation’s Annual Bleeding Disorders Meeting 2020 (virtual meeting): Aug. 1-8PDUFA DatesFDA is scheduled to rule on DBV TECHNOLOGIE/S’ ADR (NASDAQ: DBVT) Viaskin peanut allergy patch Wednesday. However, cancellation of …read more
Source:: Yahoo Finance
